G6pd Deficiency Drugs To Avoid Medscape
Drug names in red are of high risk to all deficiency variants.
G6pd deficiency drugs to avoid medscape. Neonatal jaundice may occur. The following is a partial list of medications and chemicals that individuals with glucose 6 phosphate dehydrogenase g6pd deficiency should avoid. G6pd deficiency leads to free radical mediated oxidative damage to red blood cells which in turn causes hemolysis. It is an x linked recessive disorder and thus more often affects males.
Drugs to avoid in g6pd deficiency definite risk of haemolysis possible risk of haemolysis pharmacological class drugs pharmacological class drugs ß naphthol niridazole stibophen nitrofurans nitrofurantoin nitrofurazone quinolones ciprofloxacin moxifloxacin nalidixic acid norfloxacin ofloxacin chloramphenicol sulfonamides. Glucose 6 phosphate dehydrogenase g6pd deficiency is a well known x linked genetic disorder that most commonly affects up to 25 of primarily male patients from africa asia and the mediterranean 1 2 the most common clinical manifestation is jaundice due to hemolysis of red blood cells rbc 1 a number of different factors can trigger these patients to develop hemolytic anemia which most. Aspirin acceptable up to a dose of at least 1g daily in most g6pd deficient individuals chloroquine. Most patients with glucose 6 phosphate dehydrogenase g6pd deficiency are asymptomatic.
Drugs that pose a possible risk in some persons with g6pd deficiency include the following. Started in 1995 this collection now contains 6841 interlinked topic pages divided into a tree of 31 specialty books and 736 chapters. G6pd deficiency has a high prevalence in people of african asian and mediterranean descent.